High materiality8/10
Pharvaris price target raised to $79 from $75 at Citizens
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
UBS raises Pharvaris price target to $79; current price is $37.84.
- UBS raises PHVS PT to $79.
- Current price: $37.84
Key facts
- 01
Target: $79
- 02
Posted price: $37.84
- 03
Analyst firm: UBS
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.